|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2009-3-23
|
|
pubmed:abstractText |
Using a proteomic approach, we recently identified plasma CCL8 as a potential biomarker for diagnosis of graft-vs-host-disease (GVHD) in mice as well as humans. Because mass spectrometric analysis is only semi-quantitative, a quantitative method of measuring plasma CCL8 levels in mice is needed.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1873-2399
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
37
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
525-31
|
|
pubmed:meshHeading |
pubmed-meshheading:19302923-Animals,
pubmed-meshheading:19302923-Biological Markers,
pubmed-meshheading:19302923-Blotting, Western,
pubmed-meshheading:19302923-Chemokine CCL8,
pubmed-meshheading:19302923-Cloning, Molecular,
pubmed-meshheading:19302923-Disease Models, Animal,
pubmed-meshheading:19302923-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:19302923-Female,
pubmed-meshheading:19302923-Graft vs Host Disease,
pubmed-meshheading:19302923-Humans,
pubmed-meshheading:19302923-Mice,
pubmed-meshheading:19302923-Mice, Inbred BALB C,
pubmed-meshheading:19302923-Mice, Inbred C57BL,
pubmed-meshheading:19302923-Up-Regulation
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Upregulation of plasma CCL8 in mouse model of graft-vs-host disease.
|
|
pubmed:affiliation |
Immuno-Biological Laboratories Co. Ltd., Gunma, Japan. do-ota@ibl-japan.co.jp
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
